Serum total IgE may be a biomarker among chronic pulmonary aspergillosis patients with elevated serum total IgE levels: A cohort study with pathological evaluations.

Chronic pulmonary aspergillosis biomarker immunofluorescence staining pulmonology serum total IgE

Journal

Medical mycology
ISSN: 1460-2709
Titre abrégé: Med Mycol
Pays: England
ID NLM: 9815835

Informations de publication

Date de publication:
03 Mar 2022
Historique:
received: 27 08 2021
revised: 02 01 2022
accepted: 28 01 2022
pubmed: 1 2 2022
medline: 8 3 2022
entrez: 31 1 2022
Statut: ppublish

Résumé

High serum total immunoglobulin E (IgE) levels have been reported in chronic pulmonary aspergillosis (CPA). However, researchers have not verified if they reflect the disease activity. We aimed to compare the serum total IgE levels in CPA cases with high serum IgE during an exacerbation or when stable and examined the IgE expression patterns in the lesions via immunofluorescence staining. From April 2016 to September 2019, we extracted CPA cases with elevated serum total IgE levels based on the criteria of the Infectious Diseases Society of America. We retrospectively analyzed serum total IgE levels and other parameters and eventually extracted 32 cases. The patients' serum total IgE levels were significantly higher in the exacerbation period than in the stable period (P < .0001). The median rate of change was 1.76 times (quartile 1.41-3.25). In addition, we used surgical specimens of CPA cases with high serum total IgE levels, normal serum total IgE CPA cases, and control surgical specimens and performed immunofluorescence staining with IgE, mast cell tryptase, CD138, and 4,6-diamidino-2-phenylindole. We observed multiple mast cells and plasma cells in the CPA cases regardless of the serum total IgE level. In contrast, multiple IgE-positive cells co-stained with tryptase were observed in CPA cases with high serum total IgE levels. This finding suggested that serum total IgE could serve as a biomarker for evaluating disease severity. Immunofluorescence staining suggested that IgE may play a role in pathogenesis through activation of mast cells by cross-linking in cases of CPA with high serum total IgE levels. High serum total IgE levels are common in chronic pulmonary aspergillosis. This novel study indicated that serum total IgE is a possible biomarker of the disease activity in the aforementioned condition. Immunofluorescence staining indicated a possible role of IgE in disease pathogenesis.

Identifiants

pubmed: 35098997
pii: 6517702
doi: 10.1093/mmy/myac006
pii:
doi:

Substances chimiques

Biomarkers 0
Immunoglobulin E 37341-29-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Agency for Medical Research and Development
ID : 21ek0410055

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Auteurs

Shizuka Watanabe (S)

Clinical Research Center, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan.
Department of Respiratory Medicine, University of Tokyo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Junko Suzuki (J)

Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan.

Maho Suzukawa (M)

Clinical Research Center, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan.
Asthma, Allergy and Rheumatology Center, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan.

Keita Takeda (K)

Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan.

Sahoko Imoto (S)

Clinical Research Center, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan.
Department of Respiratory Medicine, University of Tokyo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Masashi Kitani (M)

Department of Pathology, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan.

Takeshi Fukami (T)

Department of Thoracic Surgery, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan.

Yuka Sasaki (Y)

Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan.

Akira Hebisawa (A)

Department of Pathology, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan.

Hirotoshi Matsui (H)

Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans Emergency Service, Hospital Child Child, Preschool Infant

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Classifications MeSH